Literature DB >> 16394796

Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups.

Sameer Zar1, Martin J Benson, Devinder Kumar.   

Abstract

OBJECTIVES: To evaluate the differences in rectal compliance and sensory thresholds for the urge to defecate and discomfort between irritable bowel syndrome (IBS) subgroups and controls, and to correlate these parameters with rectal symptoms.
METHODS: A total of 38 IBS patients [Rome II criteria; 19 diarrhoea-predominant IBS (D-IBS), 16 constipation-predominant IBS (C-IBS), three with alternating diarrhoea and constipation IBS (Alt-IBS)] and 10 controls were studied. A barostat was used to measure rectal compliance and sensory thresholds, in the 'unprepared' rectum. The thresholds for the urge to defecate and discomfort were determined using phasic rectal balloon distension in a double random staircase sequence.
RESULTS: D-IBS had significantly lower rectal compliance and threshold for the urge to defecate compared with controls [4 ml/mmHg interquartile range (IQR) 3.99 versus 8.4 ml/mmHg IQR 5.69; P=0.001; 8 mmHg IQR 6 versus 20 mmHg IQR 4; P=0.003]. D-IBS also had significantly lower rectal compliance and threshold for the urge to defecate compared with the C-IBS group (5.8 ml/mmHg IQR 4.61; P=0.027; 16 mmHg IQR 12; P=0.003). The volume at the threshold for discomfort was significantly lower in D-IBS compared with controls (163 ml IQR 99.5 versus 212 ml IQR 147.25; P=0.016). The severity of abdominal pain and rectal symptoms showed a significantly negative correlation with rectal sensory thresholds.
CONCLUSION: This study shows that the sensory threshold for the urge to defecate and rectal compliance is significantly lower in D-IBS compared with C-IBS and controls. The consequent inability to tolerate rectal faecal loading may account for the symptoms of the passage of frequent, small-volume stools in D-IBS patients.

Entities:  

Mesh:

Year:  2006        PMID: 16394796     DOI: 10.1097/00042737-200602000-00007

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

Review 1.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

2.  Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

Authors:  Uri Ladabaum; Annie Sharabidze; Theodore R Levin; Wei K Zhao; Elaine Chung; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Craig J Pepin
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

Review 3.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

Review 5.  Fecal incontinence - Challenges and solutions.

Authors:  Nallely Saldana Ruiz; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 6.  Novel techniques to study visceral hypersensitivity in irritable bowel syndrome.

Authors:  Trinh T Truong; Bruce D Naliboff; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2008-08

7.  Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

Authors:  Muriel Larauche; Guillaume Gourcerol; Lixin Wang; Karina Pambukchian; Stefan Brunnhuber; David W Adelson; Jean Rivier; Mulugeta Million; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

8.  Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits.

Authors:  Motoyori Kanazawa; Olafur S Palsson; Syed I M Thiwan; Marsha J Turner; Miranda A L van Tilburg; Lisa M Gangarosa; Denesh K Chitkara; Shin Fukudo; Douglas A Drossman; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

Review 9.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

10.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.